Hospital do Coração do Brasil

Brasília, Federal District 70390903

0 studies enrolling now · 7 studies all time

What they study most

Acute Myocardial Infarction (AMI), Cardiovascular Risk, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Dyslipidemia, Heart Failure, Inflammation, Obesity, Overweight, Type2 Diabetes

Studies at this site

• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial — Completed
• A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed